ÂÜÀòÂÒÂ×

David R. Kaufman is a Non-Executive Director of the Board of Directors of HOOKIPA. He currently serves as a Venture Partner at Third Rock Ventures. Prior to joining Third Rock Ventures.

Dr. Kaufman was Chief Medical Officer and Head of Translational Development at The Bill & Melinda Gates Medical Research Institute, and held several leadership positions at Merck Research Laboratories, including Head of Translational Oncology, Executive Director in Clinical Oncology and Associate Director of the Merck Drug Development and Leadership Program.

Dr. Kaufman is a member of the Board of Directors of the Society for Immunotherapy of Cancer (SITC), a not-for-profit medical professional society dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. He holds a Ph.D. in Molecular Virology & Immunology from The Rockefeller University and received his M.D. from Weill Cornell Medical College of Cornell University.